Identification |
Name: | Beraprost sodium |
Synonyms: | 1H-Cyclopenta[b]benzofuran-5-butanoicacid, 2,3,3a,8b-tetrahydro-2-hydroxy-1-(3-hydroxy-4-methyl-1-octen-6-ynyl)-,monosodium salt (9CI);1H-Cyclopenta[b]benzofuran-5-butanoicacid, 2,3,3a,8b-tetrahydro-2-hydroxy-1-(3-hydroxy-4-methyl-1-octen-6-yn-1-yl)-,sodium salt (1:1);Beraprost sodium salt;Berasus;Careload;Dorner;MDL 201129;ML 1129;Procylin;TRK 100; |
CAS: | 88475-69-8 |
Molecular Formula: | C24H29NaO5 |
Molecular Weight: | 420.47 |
InChI: | InChI=1/C24H30O5.Na/c1-3-4-7-15(2)19(25)13-12-17-20(26)14-21-23(17)18-10-5-8-16(24(18)29-21)9-6-11-22(27)28;/h5,8,10,12-13,15,17,19-21,23,25-26H,6-7,9,11,14H2,1-2H3,(H,27,28);/q;+1/p-1/b13-12+;/t15?,17-,19+,20+,21-,23-;/m0./s1 |
Molecular Structure: |
|
Properties |
Appearance: | white solid |
Specification: | White Solid usageEng:Platelet aggregation inhibitor; stable analog of Prostacyclin. Antithrombotic; vasodilator (peripheral). |
Storage Temperature: | Amber Vial, -20?C Freezer, Under Inert Atmosphere |
Usage: | Platelet aggregation inhibitor; stable analog of Prostacyclin. Antithrombotic; vasodilator (peripheral). |
Safety Data |
|
|